Akash Vikal completed his M. Pharm in Pharmaceutics from ISF College of Pharmacy. His research focuses on nanotechnology-based drug delivery systems, particularly liposomes, micelles, nanoformulations, and targeted therapeutics for cancer and ocular diseases. His M. Pharm research involved the development and characterization of ferulic acid and docetaxel-loaded liposomes for breast cancer therapy using a Quality by Design (QbD) approach.
He has experience in formulation development, characterization, in vitro and in vivo evaluation, cell uptake studies, and handling advanced pharmaceutical instruments including DSC, FTIR, spray dryer, rotary evaporator, electrospinning, UV spectroscopy, and texture analyzer. His research interests also include gene delivery systems, CRISPR-based therapeutics, PROTACs, ophthalmic drug delivery, and nanocarrier-mediated therapies.
Akash Vikal has authored several research and review articles in reputed international journals including Applied Materials Today, DDTR, AAPS PharmaSciTech, Experimental Eye Research, Current Pharmaceutical Design, and Drug Delivery Letters. He is actively involved in exploring innovative pharmaceutical approaches for improved therapeutic efficacy and targeted drug delivery.
Akash Vikal completed his M. Pharm in Pharmaceutics from ISF College of Pharmacy. His research focuses on nanotechnology-based drug delivery systems, particularly liposomes, micelles, nanoformulations, and targeted therapeutics for cancer and ocular diseases. His M. Pharm research involved the development and characterization of ferulic acid and docetaxel-loaded liposomes for breast cancer therapy using a Quality by Design (QbD) approach.
He has experience in formulation development, characterization, in vitro and in vivo evaluation, cell uptake studies, and handling advanced pharmaceutical instruments including DSC, FTIR, spray dryer, rotary evaporator, electrospinning, UV spectroscopy, and texture analyzer. His research interests also include gene delivery systems, CRISPR-based therapeutics, PROTACs, ophthalmic drug delivery, and nanocarrier-mediated therapies.
Akash Vikal has authored several research and review articles in reputed international journals including Applied Materials Today, DDTR, AAPS PharmaSciTech, Experimental Eye Research, Current Pharmaceutical Design, and Drug Delivery Letters. He is actively involved in exploring innovative pharmaceutical approaches for improved therapeutic efficacy and targeted drug delivery.